HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong Woo Lee Selected Research

methyl- 4- (3- chloro- 4- methoxybenzylamino)- 8- (2- hydroxyethyl)- 7- methoxyquinazolin- 6- ylmethylcarbamate

1/2010Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong Woo Lee Research Topics

Disease

2Erectile Dysfunction
01/2010 - 12/2008
1Septic Shock (Toxic Shock Syndrome)
02/2006
1Endotoxemia
02/2006

Drug/Important Bio-Agent (IBA)

1methyl- 4- (3- chloro- 4- methoxybenzylamino)- 8- (2- hydroxyethyl)- 7- methoxyquinazolin- 6- ylmethylcarbamateIBA
01/2010
1Phosphodiesterase 5 InhibitorsIBA
12/2008
1QuinazolinesIBA
12/2008
1higenamine (norcoclaurine)IBA
02/2006

Therapy/Procedure

1Therapeutics
12/2008